Robotic surgery for stomach and esophagus junction cancer
This study tests a new robotic surgery system for a specific type of stomach-adjacent cancer. The goal is to see if the robotic approach is safe and effective in removing the tumor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with cancer at the point where the food pipe meets the stomach (gastroesophageal junction), types II or III.
- Your doctor has confirmed that the tumor can likely be removed with surgery (no spread to distant organs).
- You are in good enough health to have surgery (no severe heart, lung, kidney, or liver disease).
- You have not had prior surgery, radiation, or chemotherapy in the belly or pelvic area that would affect the operation.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a robotic surgical tool that seals blood vessels in advanced stomach cancer. It aims to see if the tool works safely and effectively during robot-assisted surgery.
This trial tests whether using a robotic arm to remove stomach cancer is safe and effective for patients who have already received chemotherapy or radiation. If you have stage III stomach cancer and are healthy enough for surgery, this approach may offer a more precise operation.
This trial compares different surgical approaches for removing Siewert type II cancer at the esophagus–stomach junction. It aims to find which operation works best for people who can have the tumor removed.
This phase 3 trial compares robot-assisted surgery to standard laparoscopic surgery for treating stomach cancer that has grown through the stomach wall (cT4a) but not spread to distant organs. The goal is to see which approach may offer better outcomes.
This study compares two surgical approaches (right side of the chest vs. left side of the chest) for removing a certain type of cancer at the gastroesophageal junction. It aims to find which approach leads to better outcomes.
This trial compares robot-assisted surgery with the standard open chest operation to remove esophagus and nearby tissue. It may help you understand which approach works better and is safer for patients whose cancer can be surgically removed.
Hear when a new Siewert Type II/III Gastroesophageal Junction Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.